Is Onconetix Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Onconetix Inc (ONCO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Onconetix Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Onconetix Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Onconetix Inc?

Muslim investors may consider investing in Onconetix Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Onconetix Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Onconetix Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Onconetix Inc updated?

The Shariah compliance status of Onconetix Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Onconetix Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Onconetix Inc?

You can check the latest Shariah compliance status of Onconetix Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ONCO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 16, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Onconetix Inc (ONCO)

Based on 6 analysts giving stock ratings to Onconetix Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Onconetix Inc. Stock Analysis ONCO

United States Health Care Nano Cap Report: 2025 Annual

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 2 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Key Statistics of Onconetix Inc (ONCO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.37$0.38

Today's Open

$0.38

Volume

463.92K

P/E Ratio (TTM)

52 Week Range

$0.36$53.55

Market Cap

360.32K

Avg. Volume

5.59M

Dividend Yield

Financial Metrics & Statements of Onconetix Inc (ONCO)

FAQ's for Onconetix Inc (ONCO)

According to Musaffa’s Shariah screening methodology, Onconetix Inc (ONCO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.